Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives.

However, mRNA itself is an exceptionally unstable molecule. This does not affect the safety of the therapy but limits its effectiveness—for example, by shortening the duration of action. A ...

To learn more about Moderna’s mRNA platform and its work against Disease X, please visit mrna-access.modernatx.com ...

When a tumor starts to grow in the body, small bits of its genetic material may break away and float off into the bloodstream. | Clinical And Molecular Dx ...

Cambridge’s DIOSynVax and Singapore’s ACM Biolabs will be jointly developing a next-generation universal bird flu vaccine with the potential for mucosal delivery to combat the next pandemic. This ...

including for work on HIV and tuberculosis, as well as a number of potential treatments for cancer. It is the latter therapeutic area that is creating the biggest interest for the future of mRNA ...

Providing the breakthrough The two mRNA vaccines against COVID-19 ... The biotech, which is based in Vancouver, Canada, works with partners to provide LNP delivery technology, and was founded ...